跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 385,697 条关于
“xanomeline and trospium chloride”
全部
385,697
临床试验
338,185
药物
4,509
机构
2,232
资讯
40,771
去年
Xanomeline-Trospium Shows Consistent Efficacy in Schizophrenia Across Pooled Phase 3 Trials
去年
Bristol Myers Squibb Presents New COBENFY Data for Schizophrenia Treatment at Psych Congress
去年
Cobenfy Shows Sustained Efficacy and Safety in Long-Term Schizophrenia Trials
去年
Xanomeline/Trospium Chloride (COBENFY™) Approved for Schizophrenia Treatment
去年
Schizophrenia Treatment Targeting Cholinergic Receptors Receives FDA Approval
去年
Zai Lab's KarXT Shows Positive Phase 3 Results for Schizophrenia Treatment in China
去年
Zai Lab's KarXT Shows Positive Phase 3 Results for Schizophrenia Treatment in China
去年
Zai Lab's KarXT Shows Positive Phase 3 Results in China for Schizophrenia
2年前
FDA Approves Cobenfy, a Novel Schizophrenia Treatment Targeting Cholinergic Receptors
去年
FDA Approves Cobenfy, a Novel Schizophrenia Treatment Targeting Cholinergic Receptors
第 1 页，共 4078 页
上一页
下一页
